Navigation Links
CYIG Awarded China's "Top 100 Enterprises" in New Pharmaceuticals, Selected as National "'Torch Plan' Key High-Tech Enterprise"

NEW YORK, Dec. 10 /Xinhua-PRNewswire-FirstCall/ -- China YCT International Group, Inc. (OTC Bulletin Board: CYIG; hereinafter the "Company") announced today that Shandong Yongchuntang Biology Technology Co. Ltd. ("Shandong YCT"), the Company's wholly-owned operating subsidiary in Shandong Province, China, has been awarded the honor of China's "Top 100 Enterprises" in the bioengineering and new pharmaceuticals sector. The award was conferred by the Small- and Medium-sized Enterprises Research Center (SMERC) of the State Development and Planning Commission (SDPC), the country's premier research institution and think tank on small- and medium-sized enterprises. The rigorous selection process for the nation's "Top 100 Enterprises by Industry" began a year ago, with final winners for over 50 industrial sectors chosen from over 10,000 enterprises nationwide. Major indicators used in the selection included sales revenue in the most recent three years, production scale and capacity, actual output, and tax contribution.

The Company also announced on the same day that Shandong Yongchuntang Biology Technology Co. Ltd. has been selected as a National "Torch Plan" Key High-Tech Enterprise. Established in 1989 and administered through the Ministry of Science and Technology, the "Torch Plan" is China's premier central government-sponsored high-tech promotion program with a mandate to promote the industrialization, commercialization and internationalization of advanced technologies throughout the country. Shandong Yongchuntang Biology Technology Co. Ltd. is the first high-tech enterprise from Sishui County to be included in the plan.

"Our selection as a leading enterprise in the highly competitive bioengineering and new pharmaceuticals field, as well as our inclusion in the National 'Torch Plan', once again attest to the strengths and capabilities of our company. These two honors represent an important milestone in our persistent pursuit of developing the highest-quality ginkgo-based health and pharmaceutical products for the benefit of the human race," said Mr. Yan Tinghe, Chairman & CEO of CYIG and Shandong YCT.

China YCT International Group, Inc., through its operating subsidiary, Shandong Yongchuntang Biology Technology Co. Ltd. ("Shandong YCT"), a corporation organized under the laws of the People's Republic of China, is engaged in the business of the distribution of gingko-based health and beauty products. All of Shandong YCT's business is currently in China.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Peter D. Zhou

Tel: +1-212-232-0120

SOURCE China YCT International Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
2. Mirus Bio Awarded Grants & Contracts of Over $5 Million
3. ICx Awarded $1.5 M Contract by Department of Homeland Security for Development of Next Generation Bio Aerosol Systems
4. ViPS Awarded Enterprise Systems Development (ESD) Contract By CMS
5. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
6. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
7. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
8. Isis Awarded $1.5 Million NIH Grant to Improve Chemical Properties of RNAi-Based Therapeutics
9. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
10. Implicit Awarded US $16.3 Million U.S. Government Contract to Develop Immunomodulatory Drug for Biodefense Threats
11. BIO-key(R) Awarded Contract to Deploy Incident Reporting System for Littleton, CO Police Department
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... uBiome, were featured on AngelList early in their initial angel funding process. Now, ... syndicate for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... to a new market research report "Oligonucleotide Synthesis Market ... Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User ... to 2020", published by MarketsandMarkets, the market is expected ... 1,078.1 Million in 2015, at a CAGR of 10.1% ...
(Date:11/24/2015)...  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General ... a.m. Israel time, at the law offices of ... 36 th Floor, Tel Aviv, Israel . ... Izhak Tamir to the Board of Directors; , election ... , approval of an amendment to certain terms of options granted to ...
Breaking Biology Technology:
(Date:11/11/2015)... Minn. , Nov. 11, 2015   MedNet Solutions ... entire spectrum of clinical research, is pleased to announce that ... in Clinical Trials (PCT) event, to be held November ... be able to view live demonstrations of iMedNet ... and learn how iMedNet has been able to ...
(Date:11/9/2015)... , Nov. 09, 2015 ... addition of the "Global Law Enforcement ... offering. --> ) has ... Law Enforcement Biometrics Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
Breaking Biology News(10 mins):